Trial
NCT06941688
Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Seoul National University Hospital
Collaborators
—
Condition
Peripheral T-cell Lymphoma (PTCL)
Intervention
Decitabine with GemOx
Why stopped
slow recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-24